Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
263
Views
6
CrossRef citations to date
0
Altmetric
Short Communications

Bioguided fractionation of hypoglycaemic component in methanol extract of Vernonia amygdalina: an in vivo study

ORCID Icon, , , , & ORCID Icon
Pages 5943-5947 | Received 24 May 2020, Accepted 24 Jul 2020, Published online: 13 Aug 2020

References

  • Asase A, Yohonu DT. 2016. Ethnobotanical study of herbal medicines for management of diabetes mellitus in Dangme west district of Southern Ghana. J Herb Med. 6(4):204–209.
  • Cardile V, Graziano ACE, Venditti A. 2015. Clinical evaluation of Moro (Citrus sinensis (L.) Osbeck) orange juice supplementation for weight management. Nat Prod Res. 29(23):2256–2260.
  • Cis J, Nowak G, Kisiel W. 2006. Antifeedant properties and chemotaxonomic implications of sesquiterpene lactones and syringin from Rhaponticum pulchrum. Biochem Syst Ecol. 34(12):862–867.
  • Cui Y, Zhang Y, Liu G. 2015. Syringin may exert sleep-potentiating effects through the NOS/NO pathway. Fundam Clin Pharmacol. 29(2):178–184.
  • Ezuruike UF, Prieto JM. 2014. The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations. J Ethnopharmacol. 155(2):857–924.
  • Gheibi S, Kashfi K, Ghasemi A. 2017. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother. 95:605–613.
  • Ijeh II, Ejike CECC. 2011. Current perspective on the medicinal potentials of Vernonia amygdalina Del. J Med Plants Res. 5(7):1051–1061.
  • Kumar A, Sunita P, Jha S, Pattanayak SP. 2016. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways. Clin Exp Pharmacol Physiol. 43(10):939–950.
  • Li M, Shi X, Chen F, Hao F. 2017. Daphnetin inhibits inflammation in the NZB/W F1 systemic lupus erythematosus murine model via inhibition of NF-κB activity. Exp Ther Med. 13(2):455–460.
  • Okoduwa SIR, Umar IA, Ibrahim S, Bello F, Habila N. 2015. Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetic patients. J Diabet Metabol Disord. 14:32.
  • Okoduwa SIR, Umar IA, Ibrahim S, Bello F, Ndidi US. 2015. Socio-economic status of patients with type 2 diabetes and hypertension attending the Ahmadu Bello University Teaching Hospital, Zaria, North-West Nigeria. Glob J Health Sci. 7(1):280–287.
  • Okoduwa SIR, Umar IA, James DB, Inuwa HM. 2017. Validation of the antidiabetic effects of Vernonia amygdalina delile leaf fractions in fortified diet-fed streptozotocin-treated rat model of type-2 diabetes. J Diabetol. 8(3):74–85.
  • Okolie UV, Okeke CE, Oli JM, Ehiemere IJ. 2008. Hypoglycemic indices of Vernonia amygdalina on postprandial blood glucose concentration of healthy humans. Afr J Biotechnol. 7:4581–4585.
  • Okpe O, Habila N, Ikwebe J, Upev VA, Okoduwa SIR, Isaac OT. 2016. Antimalaria potential of Carica papaya and Vernonia amygdalina in mice infected with Plasmodium berghei. J Tropic Med. 2016:1–6. https://doi.org/http://dx.doi.org/10.1155/2016/8738972.
  • Rabe T, Mullholland D, Van-Staden J. 2002. Isolation and identification of antibacterial compounds from Vernonia colorata leaves. J Ethnopharmacol. 80(1):91–94.
  • Tariq R, Khan KI, Masood RA, Wain ZN. 2016. Natural remedies for diabetes mellitus. Int Curr Pharm J. 5(11):97–102.
  • Toyang NJ, Verpoorte R. 2013. A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae). J Ethnopharmacol. 146(3):681–723.
  • Venditti A, Sanna C, Lorenzetti LM, Ballero M, Bianco A. 2017. New coumarinyl ethers in Daphne oleoides Schreb. collected from Sardinia Island. Chem Biodiver. 14(6):1–8.
  • Vinayagam R, Xu B. 2017. 7, 8-Dihydroxycoumarin (daphnetin) protects INS-1 pancreatic β-cells against streptozotocin-induced apoptosis. Phytomedicine. 24:119–126.
  • World Health Organisation (WHO). 2017. Global report on diabetes. Geneva. https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=4ABF4A00D380177A5BEED1A531375DDB?sequence=1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.